Glantax P 260mg Injection
Marketer
Gland Pharma Limited
Salt Composition
Paclitaxel (260mg)
Overview Glantax P 260mg Injection
Oncaspar 260mg Injection is a chemotherapy agent indicated for treating breast, pancreatic, and non-small cell lung cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your specific condition and may vary. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include nausea, vomiting, and fatigue. Serious side effects such as edema (hand/lip swelling), alopecia (hair loss), and weight increase are possible. Your doctor might prescribe additional medications to mitigate side effects. Report any unusual bruising/bleeding, sore throat, mouth sores, or fever immediately. This medication can lower blood cell counts (red and white blood cells), increasing infection risk. Regular blood tests to monitor blood cell levels and liver function are necessary. Prior to treatment, disclose any pre-existing heart, liver, or kidney conditions, or concurrent use of antimicrobial drugs. Interactions with other medications are possible; inform your doctor of all medications you are taking. This injection is contraindicated during pregnancy and lactation. Effective contraception for both partners is crucial during therapy to prevent pregnancy.
Primary Ingredients of Glantax P 260mg Injection
No information provided. Therefore, no rephrased text can be offered.
Uses of Glantax P 260mg Injection
Cancers of the breast, lung (non-small cell type), and pancreas
Major Benefits of Glantax P 260mg Injection:
This medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
Common Side effects of Glantax P 260mg Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Glantax P 260mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Glantax P 260mg Injection works:
Glantax P 260mg Injection is a cancer treatment that disrupts the microtubule networks essential for cancer cell division and proliferation. This action inhibits cancer growth, ultimately leading to cell death.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Glantax P 260mg Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Glantax P 260mg Injection is contraindicated during pregnancy due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Seek medical advice before use.
Breast feedingUNSAFE
Administering Glantax P 260mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Glantax P 260mg Injection may induce adverse reactions potentially impairing driving ability. While driving between treatment cycles isn't inherently prohibited, the injection's alcohol content suggests caution regarding driving.
KidneySAFE IF PRESCRIBED
The 260mg Glantax P injection presents no need for dosage modification in individuals with kidney conditions and is considered safe for their use. Nevertheless, consultation with a physician is advisable for patients with pre-existing kidney disease.
LiverCAUTION
The 260mg Glantax P injection requires careful administration in individuals with hepatic impairment. Dosage modification for Glantax P 260mg Injection may be necessary. Physician consultation is advised. Glantax P 260mg Injection is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Glantax P 260mg Injection :
NA
Facts to Know About Glantax P 260mg Injection
| Label | Value |
|---|---|
| Chemical Type | Taxane Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Treatments |
| Action Class | Taxanes: Antimicrotubule Agents |
3,018 People bought this recently